ADNKA overcomes SARS-CoV2-mediated NK cell inhibition through non-spike antibodies (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.04.06.438630

Publication URI: http://dx.doi.org/10.1101/2021.04.06.438630

Type: Preprint